A federal poverty-fighting program focused on reducing unintended pregnancies is about to undergo a major overhaul. Reproductive health clinics use Title X federal grant money to provide birth control, cancer screenings and testing and treatment for sexually transmitted infections to people with little or no health insurance. Title X money cannot be used for abortions.
Source
The U.S. Food and Drug Administration (FDA) has launched a study that purports to examine the safety of the widely used abortion medication mifepristone, a move that critics say could be used as a means to further regulate the drug and restrict abortion access. FDA administrators deny that the study, revealed in a Wall Street Journal report late last week, is new, asserting it has been going…
Source
On May 1, the New Orleans-based 5th U.S. Circuit Court of Appeals blocked the mailing of mifepristone, a common abortion medication. The ruling restricted distribution and use of the medication to in-person clinic visits only, even as the number of brick-and-mortar abortion clinics has continued to shutter over the past year, and some red states blocked access to mail order pills.
Source
In the aftermath of the Dobbs v. Jackson Women’s Health Organization Supreme Court decision that overturned Roe v. Wade, there has been increased movement toward criminalization of abortion. The Fifth Circuit Court recently ordered the Food and Drug Administration (FDA) to rescind guidance permitting the use of telemedicine for mifepristone, one of the two medications used for medication…
Source
Rights advocates swiftly sounded the alarm on Friday after the infamously far-right U.S. Court of Appeals for the 5th Circuit temporarily blocked a federal rule allowing mifepristone to be dispensed by mail, dramatically curtailing access to the medication — commonly used for abortion and early miscarriage care — nationwide, particularly in states with policies hostile to reproductive freedom.
Source
In the relentless nightmare that is the post-Roe United States, it can be hard to find the bright spots for abortion rights. Maternal mortality rates in states with abortion bans are increasing. South Carolina, which already has a draconian six-week abortion ban in effect, is now debating whether to ban nearly all abortions in the state. The future of mifepristone access remains murky and tenuous…
Source